{"biological_condition":["Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturer’s protocol "],"cell_line":["C2C12 (myoblasts)"],"identifier":["29618024","EXP051558","GSE69527","GSM1702885"],"jaspar_id":["MA0499.2"],"prediction_models":["DAMO"],"tf_id":"EXP051558.C2C12_myoblasts.MYOD1","tf_name":"MYOD1","tfbs":[{"DAMO":[{"adj_centrimo_pvalue":0.0,"distance_threshold":"5","jaspar_id":"MA0499","jaspar_version":"2","score_threshold":"83.8","total_tfbs":"2236","model_detail":"","bed_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP051558.C2C12_myoblasts.MYOD1/EXP051558.C2C12_myoblasts.MYOD1.MA0499.2.damo.bed","fasta_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP051558.C2C12_myoblasts.MYOD1/EXP051558.C2C12_myoblasts.MYOD1.MA0499.2.damo.fa","summary_plot_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP051558.C2C12_myoblasts.MYOD1/EXP051558.C2C12_myoblasts.MYOD1.MA0499.2.damo.png"}]}],"total_peaks":"43786"}